Scholarlink

Background <p>Breast cancer remains the most commonly diagnosed cancer type among women, with a high mortality rate due to metastasis. Chemotherapy remains very aggressive, with burdensome side effects on the body. <i>Tecoma stans</i> is an ornamental plant widely used to treat many diseases according to its various pharmacological properties. This study aimed to investigate the cytotoxic, antiproliferative, and antimetastatic activities of <i>Tecoma stans</i> leaves &amp; flowers methanolic extract (TSLME &amp;TSFME) on a highly metastatic MDA-MB-231 breast cancer cell line.</p> Methods <p>Gas chromatography-mass spectrometry (GC–MS) analysis of TSLME and TSFME was carried out to identify present bioactive compounds. TSLME and TSFME were used to assess their cytotoxic (Trypan Blue Exclusion Assay), antiproliferative (MTT Assay), and anti-metastatic activity (Wound Healing Assay) on the triple-negative breast cancer cell line MDA-MB-231, along with their impact on the morphology of metastatic cells.</p> Results <p>TSLME showed significantly higher cytotoxicity on MDA-MB-231 cancer cells compared to TSFME at 800&#xa0;µg/mL. On the contrary, at 200 and 100&#xa0;µg/mL, TSFME exhibited a more robust antiproliferative effect than TSLME. Additionally, TSLME and TSFME exhibited a significant inhibitory effect on the cell motility upon 24&#xa0;h at 48&#xa0;h incubations. Moreover, TSLME and TSFME induced apoptosis in MDA-MB-231 cells and altered their morphology at different concentrations (Decrease in the cell surface area, plasma membrane bleb formation, and nuclear condensation). TSLME and TSFME significantly reduced the cell body and field diameter and process thickness of MDA-MB-231 cells at 800&#xa0;µg/mL (TSLME &gt; TSFME) and at 200&#xa0;µg/mL (TSFME &gt; TSLME) which can be an indicator of cell cycle arrest as a response to cellular stress or DNA damage. The pharmacological activities demonstrated in this research by TSLME and TSFME can be attributed to numerous bioactive molecules detected through GC–MS analysis with anticancer activities. These compounds may have acted singularly or synergistically in a concentration-dependent manner.</p> Conclusion <p>This study revealed the cytotoxic, antiproliferative, and antimetastatic effects of <i>Tecoma stans.</i> Following in-depth in vivo research and clinical trials, <i>Tecoma stans</i> could therefore be used as a promising chemotherapeutic drug against highly metastatic human breast cancer cell lines.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of cytotoxic, anti-proliferative, anti-metastatic, and morphometric effects of Tecoma stans extracts against MDA-MB-231 human breast cancer cell line

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月12日

查看全文
  • Steve Willy Tchabewu Mbianda,
  • Nahit Rizaner,
  • Ovgu Isbilen

摘要

Background

Breast cancer remains the most commonly diagnosed cancer type among women, with a high mortality rate due to metastasis. Chemotherapy remains very aggressive, with burdensome side effects on the body. Tecoma stans is an ornamental plant widely used to treat many diseases according to its various pharmacological properties. This study aimed to investigate the cytotoxic, antiproliferative, and antimetastatic activities of Tecoma stans leaves & flowers methanolic extract (TSLME &TSFME) on a highly metastatic MDA-MB-231 breast cancer cell line.

Methods

Gas chromatography-mass spectrometry (GC–MS) analysis of TSLME and TSFME was carried out to identify present bioactive compounds. TSLME and TSFME were used to assess their cytotoxic (Trypan Blue Exclusion Assay), antiproliferative (MTT Assay), and anti-metastatic activity (Wound Healing Assay) on the triple-negative breast cancer cell line MDA-MB-231, along with their impact on the morphology of metastatic cells.

Results

TSLME showed significantly higher cytotoxicity on MDA-MB-231 cancer cells compared to TSFME at 800 µg/mL. On the contrary, at 200 and 100 µg/mL, TSFME exhibited a more robust antiproliferative effect than TSLME. Additionally, TSLME and TSFME exhibited a significant inhibitory effect on the cell motility upon 24 h at 48 h incubations. Moreover, TSLME and TSFME induced apoptosis in MDA-MB-231 cells and altered their morphology at different concentrations (Decrease in the cell surface area, plasma membrane bleb formation, and nuclear condensation). TSLME and TSFME significantly reduced the cell body and field diameter and process thickness of MDA-MB-231 cells at 800 µg/mL (TSLME > TSFME) and at 200 µg/mL (TSFME > TSLME) which can be an indicator of cell cycle arrest as a response to cellular stress or DNA damage. The pharmacological activities demonstrated in this research by TSLME and TSFME can be attributed to numerous bioactive molecules detected through GC–MS analysis with anticancer activities. These compounds may have acted singularly or synergistically in a concentration-dependent manner.

Conclusion

This study revealed the cytotoxic, antiproliferative, and antimetastatic effects of Tecoma stans. Following in-depth in vivo research and clinical trials, Tecoma stans could therefore be used as a promising chemotherapeutic drug against highly metastatic human breast cancer cell lines.